CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, net loss was USD 3.86 million compared to USD 4.89 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.